Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis
Phase 3
Completed
- Conditions
- Carcinoma, HepatocellularHepatitis, Viral, Human
- Interventions
- Drug: 131 I-lipiodol
- First Posted Date
- 2005-06-30
- Last Posted Date
- 2013-09-23
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 73
- Registration Number
- NCT00116454
- Locations
- 🇫🇷
Service d'Hépatologie Hôpital Saint Antoine, Paris, France
© Copyright 2025. All Rights Reserved by MedPath